Development and Use of New Therapeutics for Rare Diseases: Views from Patients, Caregivers, and Advocates
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1007/s40271-014-0096-6.pdf
Reference32 articles.
1. Selby JV. Patient-Centered Outcomes Research Institute seeks to find out what works best by involving ‘end-users’ from the beginning. J Comp Eff Res. 2014;3(2):125–9.
2. Fleurence R, Selby JV, Odom-Walker K, Hunt G, Meltzer D, Slutsky JR, Yancy C. How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda. Health Aff. 2013;32(2):393–400.
3. Mirzaei M, Aspin C, Essue B, Jeon YH, Dugdale P, Usherwood T, Leeder S. A patient-centred approach to health service delivery: improving health outcomes for people with chronic illness. BMC Health Serv Res. 2013;13:251.
4. Kesselheim AS. Off-label drug use and promotion: balancing public health goals and commercial speech. Am J Law Med. 2011;37:225–57.
5. Buckley BM. Clinical trials of orphan medicines. Lancet. 2008;371:2051–5.
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A scoping review of health literacy in rare disorders: key issues and research directions;Orphanet Journal of Rare Diseases;2024-09-06
2. Experiences of quality of life and access to health services among rare disease caregivers: a scoping review;Orphanet Journal of Rare Diseases;2024-08-31
3. Morally Problematic Situations Encountered by Adults Living With Rare Diseases;AJOB Empirical Bioethics;2023-12-14
4. The advantages of rare disease biobanking: A localised source of genetic knowledge to benefit the South African rare disease community and related stakeholders worldwide;South African Medical Journal;2023-12-04
5. Determining Commonalities in the Experiences of Patients with Rare Diseases: A Qualitative Analysis of US Food and Drug Administration Patient Engagement Sessions;The Patient - Patient-Centered Outcomes Research;2023-10-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3